Citadel Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.75M Sell
1,361,105
-473,403
-26% -$1.7M ﹤0.01% 4428
2025
Q4
$6.27M Buy
1,834,508
+825,893
+82% +$3.69M ﹤0.01% 3939
2025
Q3
$5.07M Sell
1,008,615
-1,881,145
-65% -$8.29M ﹤0.01% 4340
2025
Q2
$9.91M Buy
2,889,760
+1,075,286
+59% +$2.68M 0.01% 3033
2025
Q1
$4.05M Buy
1,814,474
+1,217,223
+204% +$3.49M ﹤0.01% 4238
2024
Q4
$1.75M Sell
597,251
-902,389
-60% -$2.51M ﹤0.01% 5911
2024
Q3
$3.9M Buy
1,499,640
+26,430
+2% +$73.2K ﹤0.01% 4350
2024
Q2
$4.36M Buy
1,473,210
+708,377
+93% +$2.68M ﹤0.01% 3963
2024
Q1
$3.46M Buy
764,833
+186,527
+32% +$952K ﹤0.01% 4555
2023
Q4
$3.3M Sell
578,306
-171,425
-23% -$794K ﹤0.01% 4490
2023
Q3
$3.45M Sell
749,731
-1,444,039
-66% -$8.78M ﹤0.01% 4247
2023
Q2
$14.2M Buy
2,193,770
+719,890
+49% +$4.91M 0.02% 2248
2023
Q1
$11.1M Buy
1,473,880
+8,884
+0.6% +$80.7K 0.01% 2673
2022
Q4
$14.8M Buy
1,464,996
+968,448
+195% +$11.2M 0.02% 2310
2022
Q3
$4.91M Buy
496,548
+329,348
+197% +$3.61M 0.01% 3907
2022
Q2
$1.78M Sell
167,200
-1,942
-1% -$16.4K ﹤0.01% 5787
2022
Q1
$1.65M Sell
169,142
-248,948
-60% -$2.36M ﹤0.01% 6523
2021
Q4
$5.98M Buy
418,090
+57,471
+16% +$872K 0.01% 3989
2021
Q3
$7.23M Sell
360,619
-42,990
-11% -$760K 0.01% 3633
2021
Q2
$8.88M Buy
403,609
+263,034
+187% +$7.25M 0.01% 3276
2021
Q1
$4.77M Sell
140,575
-291,782
-67% -$11.6M 0.01% 4358
2020
Q4
$17.4M Buy
+432,357
New +$19.8M 0.02% 1953

Other funds holding ABCL